VA-REGULA
23.4.2024 09:01:33 CEST | Business Wire | Press release
In addition to the clear risks, such as an increase in fraud, attracting new foreign customers presents less apparent challenges, including the absence of standardized documentation and language barriers. These are the results of a global survey conducted by Regula, a global developer of forensic devices and identity verification solutions.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240423489077/en/
Top problems businesses deal with when verifying foreign IDs, according to Regula’s survey (Graphic: Business Wire)
Key challenges for businesses
When it comes to identity verification for international customers, including a growing community of digital nomads, organizations from various industries participating in Regula’s survey tend to point out the following challenges:
- The lack of unified document standards. 41% of decision-makers in all sectors report a significant challenge due to the lack of standardized identity documents. This inconsistency affects the efficiency and speed of IDV processes. For government services, the problem seems to be even worse, since 48% of the respondents in this sphere named this issue as the main challenge.
- The increase in fraud. Identity-related fraud continues to be a major concern, affecting 40% of businesses overall. Higher impacts of fraud are observed in Banking and Financial Services (48% of respondents call it a key challenge) and Retail (44% of respondents).
- Language barriers. Complexities due to language differences are reported by 36% of businesses. For the Healthcare and Insurance industries, this is an even greater concern, with 41% and 39% of respondents correspondingly naming it among the top three challenges.
Dealing with new identity documents and facing new risks, organizations strive to pursue a high level of identity verification (IDV) security and accuracy, with every third of them expressing the need for an increase in their IDV budget by up to 20%.
"As the world is starting to pilot the concept of digital IDs, it is possible that in the foreseeable future, we will achieve a certain level of identity document standardization. That means some of the current challenges in international ID verification will likely be mitigated,” says Henry Patishman, Executive Vice President of Identity Verification Solutions at Regula. “In the meantime, both businesses and IDV providers have to concentrate on tackling fraud and language barriers. From our experience, we see that there are two effective ways of dealing with these issues: enhancing the set of document and biometric checks, with a strong emphasis on data cross-checks to spot any possible inconsistencies that may indicate fraud, and growing your own document knowledge database to be able to read any document in any language correctly.”
Major concerns for customers
In their turn, digital nomads who settle in foreign countries for short or long periods of time also face challenges related to identity verification. Predominantly, their concerns revolve around the document validity period, which has an expiry date and proof of residency, such as rental agreements or utility bills. Each of these issues is a challenge for 19% of Regula’s survey respondents.
Apart from that, 18% of digital nomads have difficulties with ID verification because of their frequent travel and changing locations, which create inconsistencies in the information provided, and potentially lead to delays or rejection in identity proofing. Another 18% of respondents feel a lack of trust and credibility from institutions due to the unconventional nature of their lifestyle and work arrangements.
As for the language barrier, 70% of digital nomads say they have encountered language difficulties in understanding the instructions during the verification process. However, only 16% of nomads cite language barriers as a top frustration during the ID verification process. At the same time, twice as many digital nomads (36%) feel frustrated because of Internet connectivity issues: majorly relying on public Wi-Fi networks, they face an increased risk of cybersecurity threats and data breaches during the verification process.
The research has also shown that only 29% of nomads are very comfortable with providing sensitive identification documents online while being in a foreign country.
To learn more about the concerns and frustrations for both businesses and digital nomads, read the full report on the survey. To find out how to cope with various difficulties during the identity verification process, please visit Regula’s solutions page and learn about the advanced technologies for document and biometric checks.
*The research was initiated by Regula and conducted by Sapio Research in September 2023 using an online survey of digital nomads and Fraud Prevention decision makers across the Software/Tech, Financial and Banking Services, Technology, Telecoms, Travel and Hospitality sectors, and others. The respondent geography included the US, UK, Germany, Spain, UAE, and Mexico.
Resources:
- Blog article Identity Verification in a Globalized World -– https://regulaforensics.com/blog/identity-verification-in-nomad-era-research/
- Survey report Identity Verification in a Globalized World – https://regulaforensics.com/resources/identity-verification-for-digital-nomads-report/
- Regula Document Reader SDK – https://regulaforensics.com/products/document-reader-sdk/
- Regula Face SDK – https://regulaforensics.com/products/face-recognition-sdk/
About Regula
Regula is a global developer of forensic devices and identity verification solutions. With our 30+ years of experience in forensic research and the largest library of document templates in the world, we create breakthrough technologies in document and biometric verification. Our hardware and software solutions allow over 1,000 organizations and 80 border control authorities globally to provide top-notch client service without compromising safety, security or speed. Regula was repeatedly named a Representative Vendor in the Gartner® Market Guide for Identity Verification.
Learn more at www.regulaforensics.com.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20240423489077/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
From Network Automation to Agentic NetOps: NetBrain Sets the Standard for Deploying AI in Network Operations29.5.2026 15:00:00 CEST | Press release
Newest expansion of the NetBrain platform delivers Agent Skills, AI Path Doctor, MCP Server, and expanded cross-domain integrations, extending the agentic capabilities already running in production at hundreds of enterprises. NetBrain Technologies, Inc. today announced major new platform features that advance Agentic NetOps from an emerging category to operational reality. NetBrain's clients are already deploying agents that are diagnosing and remediating issues across complex multi-vendor enterprise networks. These new features further extend the platform with new agent tooling, cross-domain context, and open interfaces for the broader agentic enterprise. Early customer outcomes show the magnitude of the shift: A leading health insurer used NetBrain's Deep Diagnosis agent to diagnose and resolve a weeks old VPN connectivity issue in under five minutes. A large manufacturer resolved a critical device issue with a single prompt, isolating the root cause across the network path in under
Adtran resolves long-running patent litigation, reinforcing commitment to defend innovation29.5.2026 14:00:00 CEST | Press release
News summary: Non-practicing entity litigation continues to create costly, time-consuming pressure across the technology industry Adtran has reached a full settlement following counterclaims, with payment made to Adtran and all claims dismissed with prejudice Outcome reflects Adtran’s commitment to defend its innovations, customers and business against meritless patent assertions Adtran today announced it has resolved a patent litigation matter, resulting in a full settlement and dismissal of all claims with prejudice. The case, initiated in 2020 by a non-practicing entity asserting five patents, was transferred to the US District Court for the Northern District of Alabama in 2021 following a successful motion by Adtran. Adtran subsequently filed counterclaims, including bad-faith patent assertion under Alabama statutory law. The settlement includes payment to Adtran to resolve its counterclaims. Terms of the agreement remain confidential. “This outcome reflects a disciplined and consi
Meiji Seika Pharma Invests in GHIC’s Global Health Security Fund29.5.2026 13:00:00 CEST | Press release
Meiji Seika Pharma Co., Ltd. (Headquarters: Tokyo, Japan; President and Representative Director: Toshiaki Nagasato) today announced that it has committed to invest in the Global Health Security Fund (GHSF), which is sponsored by Global Health Investment Corporation (GHIC), a New York-based nonprofit organization. Through this investment, Meiji Seika Pharma will support the acceleration of innovations addressing critical global health challenges, including pandemic preparedness and antimicrobial resistance (AMR). GHIC is a mission‑driven nonprofit organization that deploys private investment strategies to generate both global health impact and financial returns. GHIC recently closed its second fund in GHSF. With more than a decade of experience investing in the field of infectious disease, GHIC has contributed to addressing major global health challenges. Its portfolio companies have successfully commercialized more than a dozen products, collectively reaching over 600 million people wo
IFF Enters Into Agreement to Sell Its Food Ingredients Business to CVC29.5.2026 12:50:00 CEST | Press release
Transaction advances portfolio transformation, sharpens focus on higher-growth, higher-margin businesses, strengthens balance sheet, and enhances value creation for shareholders IFF (NYSE: IFF), a global leader in flavors, fragrances, food ingredients, and health and biosciences, today announced that it has entered into an agreement to sell its Food Ingredients business to funds advised by CVC Capital Partners, a leading global private markets manager, in a transaction that values the business at approximately $4.3 billion, representing an enterprise value-to-EBITDA multiple of approximately 10x. As part of the transaction, IFF has chosen to retain an approximately 10% minority equity interest in the business, or approximately $200 million, permitting continued collaboration and cooperation between IFF and Food Ingredients and allowing IFF and its shareholders to participate in future value creation under its new ownership. The transaction marks a significant step in IFF’s portfolio tr
BeOne Medicines Establishes Standard for Long-Term Disease Control in CLL with BRUKINSA 78-Month Data at ASCO 202629.5.2026 12:00:00 CEST | Press release
Data represents the longest reported follow-up for a next-generation BTK inhibitor in CLL, showing sustained disease control and benefit that extends beyond first-line therapyBRUKINSA plus next-generation BCL2 inhibitor sonrotoclax (ZS) delivered deep, durable, and rapid uMRD responses, raising the bar for potential time-limited treatments in CLLData reinforce BeOne’s leadership in CLL and the strength of its foundational hematology franchise BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, is advancing the treatment paradigm in chronic lymphocytic leukemia (CLL) at the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting. With extensive long-term follow-up, the SEQUOIA study of BRUKINSA® (zanubrutinib) reinforces its role as the foundational BTK inhibitor, showing sustained disease control over years of therapy. These findings are further supported by real-world evidence across three large analyses encompassing more than 250,000 pati
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
